How Well Do Opioid Peptides Cross the Gut Barrier? Transport Across Intestinal Cell Monolayers

Mu-opioid receptor agonist and antagonist peptides showed varying permeability across Caco-2 intestinal monolayers, with some achieving meaningful transport — assessing the oral bioavailability potential of opioid peptides.

Iwan, Małgorzata et al.·Peptides·2008·Preliminary Evidencein-vitro
RPEP-01358In VitroPreliminary Evidence2008RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Mu-opioid peptide agonists and antagonists showed variable Caco-2 monolayer permeability, with some achieving transcellular transport — assessing oral bioavailability potential and identifying which opioid peptide structures achieve gut barrier crossing.

Key Numbers

How They Did This

in-vitro study.

Why This Research Matters

Relevant for opioid-peptides, bioactive-food-peptides, bioavailability.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Mu-opioid peptide agonists and antagonists showed variable Caco-2 monolayer permeability, with some achieving transcellular transport — assessing oral
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2008.
Original Title:
Transport of micro-opioid receptor agonists and antagonist peptides across Caco-2 monolayer.
Published In:
Peptides, 29(6), 1042-7 (2008)
Database ID:
RPEP-01358

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

How Well Do Opioid Peptides Cross the Gut Barrier? Transport Across Intestinal Cell Monolayers

What was found?

Mu-opioid receptor agonist and antagonist peptides showed varying permeability across Caco-2 intestinal monolayers, with some achieving meaningful transport — assessing the oral bioavailability potential of opioid peptides.

Read More on RethinkPeptides

Cite This Study

RPEP-01358·https://rethinkpeptides.com/research/RPEP-01358

APA

Iwan, Małgorzata; Jarmołowska, Beata; Bielikowicz, Krzysztof; Kostyra, Elzbieta; Kostyra, Henryk; Kaczmarski, Maciej. (2008). Transport of micro-opioid receptor agonists and antagonist peptides across Caco-2 monolayer.. Peptides, 29(6), 1042-7. https://doi.org/10.1016/j.peptides.2008.01.018

MLA

Iwan, Małgorzata, et al. "Transport of micro-opioid receptor agonists and antagonist peptides across Caco-2 monolayer.." Peptides, 2008. https://doi.org/10.1016/j.peptides.2008.01.018

RethinkPeptides

RethinkPeptides Research Database. "Transport of micro-opioid receptor agonists and antagonist p..." RPEP-01358. Retrieved from https://rethinkpeptides.com/research/iwan-2008-transport-of-microopioid-receptor

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.